Oric Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $1,538 |
Gross Profit | -272 | -261 | 1,275 | |
EBITDA | -38,048 | -35,745 | -28,729 | -31,165 |
EBIT | -38,318 | -36,017 | -28,990 | -31,428 |
Net Income | -34,566 | -31,963 | -25,011 | -28,330 |
Net Change In Cash | 0 | 0 | 0 | 1,538 |
Free Cash Flow | -29,215 | -25,958 | -30,572 | -24,554 |
Cash | 44,230 | 49,831 | 56,360 | 23,384 |
Basic Shares | 70,542 | 70,348 | 67,349 | 57,464 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,032 | -966 | -897 | -970 |
EBITDA | -109,748 | -91,767 | -77,974 | -74,186 |
EBIT | -110,780 | -92,733 | -78,871 | -75,156 |
Net Income | -100,697 | -91,477 | -77,677 | -97,270 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -159,166 | 148,028 | -10,713 | |
Free Cash Flow | -86,537 | -77,221 | -60,480 | -45,935 |
Cash | 23,384 | 66,840 | 226,006 | 78,446 |
Basic Shares | 51,450 | 39,655 | 37,954 | 21,942 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.49 |
2024-06-30 | -$0.45 |
2024-03-31 | -$0.37 |
2023-12-31 | -$0.49 |
